Ankiti Bose’s name has long been associated with one of Asia’s most dramatic startup stories. But her next chapter may have very little to do with the past.
The entrepreneur and investor, who first became known as the co-founder of Zilingo, is now building through Terra Invest — a global investment and operating platform with a footprint across Miami, London, Abu Dhabi and the wider Middle East.
It marks a significant evolution for Bose. Her early career moved at extraordinary speed: McKinsey & Co, venture capital, then the creation of a cross-border technology company before the age of 30. She became one of the rare Indian women to build at scale in Southeast Asian technology and appeared on global recognition lists including Forbes Asia 30 Under 30, Fortune 40 Under 40 and Bloomberg 50.
But after years of public attention and corporate conflict, Bose’s current focus appears to be less about visibility and more about institution-building.
Terra Invest has been positioned as a platform that blends financial expertise with public-policy insight, with a focus on artificial intelligence, healthcare, life sciences, blockchain-enabled financial technology, renewable energy and other regulated frontier sectors. Its partner network includes names such as former US Ambassador Kirk Wagar and entrepreneur and private equity executive Krishan Rattan.
The thesis behind Terra Invest feels particularly current. The next generation of large companies may not emerge only from consumer apps or conventional venture bets. They may come from fields where science, regulation and capital converge: longevity, AI diagnostics, precision medicine, clean energy, fintech infrastructure and healthcare platforms.
That is where Terra appears to be placing its attention.
For Bose, the Middle East has become central to the story. Dubai and Abu Dhabi are increasingly positioning themselves as global hubs for AI, healthcare innovation, capital formation, luxury services and medical tourism. The UAE’s appetite for future-facing sectors gives founders and investors a rare combination of speed, ambition and policy support.
In Dubai, Terra Invest has been linked with healthcare and regenerative wellness platforms combining AI, biotechnology and medical aesthetics. The category reflects a broader global shift from reactive healthcare and traditional beauty treatments toward prevention, optimisation, diagnostics and measurable longevity.
It is a sharp pivot from Bose’s earlier association with fashion supply chains and e-commerce. Yet the underlying instinct is consistent: build platforms in large, fragmented markets where technology, capital and consumer demand can be reorganised at scale.
The difference now is that the sectors are more institutional.
Longevity, healthcare, AI and renewable energy are not simple venture themes. They involve regulatory complexity, capital intensity, trust and governance. Terra Invest’s positioning suggests an attempt to build across precisely those intersections.
That is why Bose’s comeback is not best understood as a return to public life. It is better understood as a move into a larger arena.
For India and Southeast Asia, her trajectory also raises a broader question about founder culture. Highly visible women founders are often celebrated quickly and scrutinised harshly, while male founders are often allowed to fail, pivot and return with new ventures. Bose’s new chapter may become a useful test of whether second acts are reserved for some founders or available to all.
What is already clear is that Bose is not building around nostalgia. She is not trying to recreate the last decade’s e-commerce moment. She is moving toward sectors that may define the next one.
Artificial intelligence. Longevity. Healthcare. Frontier capital. Policy-led investing. The Middle East.
The comeback story, in other words, is not about what Ankiti Bose once built.
It is about what she is building now — and whether Terra Invest becomes the platform through which she defines her next decade.
